A detailed history of Zweig Di Menna Associates LLC transactions in Natera, Inc. stock. As of the latest transaction made, Zweig Di Menna Associates LLC holds 242,625 shares of NTRA stock, worth $40.9 Million. This represents 3.24% of its overall portfolio holdings.

Number of Shares
242,625
Previous 77,525 212.96%
Holding current value
$40.9 Million
Previous $8.4 Million 267.33%
% of portfolio
3.24%
Previous 0.99%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$97.75 - $129.67 $16.1 Million - $21.4 Million
165,100 Added 212.96%
242,625 $30.8 Million
Q2 2024

Jul 24, 2024

BUY
$85.28 - $112.6 $6.61 Million - $8.73 Million
77,525 New
77,525 $8.4 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Zweig Di Menna Associates LLC Portfolio

Follow Zweig Di Menna Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zweig Di Menna Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zweig Di Menna Associates LLC with notifications on news.